Default Theme
AIIMS NEW
अखिल भारतीय आयुर्विज्ञान संस्थान, नई दिल्ली
All India Institute Of Medical Sciences, New Delhi

DR. AJAY GOGIA

Curriculum Vitae

 

 

Ajay Gogia, MD, DM, is an Additional Professor in the Department of Medical Oncology at Dr. B.R.A Institute-Rotary Cancer Hospital All India Institute of Medical Sciences (AIIMS), New Delhi, India. He received his M.B.B.S, MD (Internal Medicine) degree from Banaras Hindu University, DM (Medical Oncology) from AIIMS, New Delhi. He has over 17 year of working and teaching experience in Medical Oncology and specializes in All variants of Breast Cancer, Non-Hodgkin’s Lymphoma,Chronic lymphocytic leukemia, Hodgkin Lymphoma and Multiple Myeloma. He has gained his International exposurein Europe,United states of America (USA), United Kingdom (UK) and Canada throughmultiple fellowships and honoured observerships.. His research is well published with more than 400 peer reviewed articles in National and International oncology journals and is well citedover thousand citations . His letters and correspondence are well accepted and published in reputed journalslike New England journal of Medicine (NEJM), Lancet Oncology, Journal of clinical oncology (JCO) and JAMA Oncology. He has received Dronacharya Award for his excellence by Health Minister ,Thrice Golden aim Award for teaching, patient care and research and best researcher award from Global forum of Artificial Intelligene and Robotics. He is actively involve in management of breast cancer in every aspects :prevention, screening, chemotherapy, hormonal therapy, targeted therapy and immuunotherapy

 

 

Name : Dr. Ajay Gogia

Qualifications : MBBS,

MD (Internal Medicine),

DM (Medical Oncology)

Current Appointment : Additional Professor

Department of Medical Oncology, Dr. B.R.A, I.R.C.H,

All India Institute of Medical Sciences (AIIMS)

Ansari Nagar, New Delhi, 110029

Nationality : Indian

 

Education and Qualifications

Degree

University

Year

MBBS

Institute of Medical Sciences, Banaras Hindu University, Varanasi-India

2000

M.D (Internal Medicine)

Institute of Medical Sciences, Banaras Hindu University, Varanasi-India

2003

D.M. (Medical Oncology)

All India Institute of Medical Sciences(AIIMS),New Delhi, India

2011

  

Working place and post

Post

University/ INSTITUTE

Year

Senior Residency and D.M ( Doctrate of medicine)

( Medical Oncology)

All India Institute of Medical Sciences(AIIMS),

New Delhi, India

2006-11

SeniorResearch Associate

(Pool Officer)

All India Institute of Medical Sciences(AIIMS), New Delhi, India

2011-12

Assistant Professor

All India Institute of Medical Sciences(AIIMS), New Delhi, India

2013- 2016

Associate Professor

All India Institute of Medical Sciences(AIIMS), New Delhi, India

2017- 2019

Additional Professor

All India Institute of Medical Sciences(AIIMS), New Delhi, India

2020-till date

 

Working&TEACHING experienec in medical oncology:17 years

Specific Area of Interest

OPD Schedule and timing

Member of the multidisciplinary teams of Breast cancer clinic (BCC) and lymphoma clinic at Dr. B.R.A-IRCH, All India Institute of Medical Sciences (AIIMS)and taking care of Medical Management of Breast cancer, B-cell Non Hodgkin lymphoma,Hodgkin Lymphoma, Multiple myeloma andChronic lymphocytic leukemia’s

Breast Cancer

 

Monday (2.00pm, Breast cancer clinic, Board Room).Wednesday (9.30 am), Adult Medical Oncology clinic, Board Room

Friday (9.30 am ) Adult Medical Oncology clinic, Room No 1

Non-Hodgkin and Hodgkin Lymphoma,Chronic lymphocytic leukemia (CLL) and Multiple Myeloma

Thursday (9.30 am, Lymphoma and Myeloma clinic, Room No. 4), Wednesday and Friday (9.30 am, Adult Medical Oncology Clinic, Board Room)

 

Fellowship

PLACE

Year

Indian American cancer Association-(IACA) Fellowship

Cleveland Clinic. OHIO, United States of America (USA)

Mentor: Prof. Jame Abraham

2016

European Society Of Medical Oncology (ESMO) Fellowship

Jules Bordet Hospital, Brussels

Mentor: Prof. Martine Piccart

2017

 

MD Anderson Cancer center (MDACC) short term fellowship

MDACC, Houston, Texas,USA

Mentor :Prof. Hagop M.Kantarjian / Prof. Jain

2018

ESMO- Palliative care fellowship

 

Princess Margaret Cancer CentreToronto,Canada

Mentor : Prof. Subratha Banerjee

2019

 

Hounoured Observer- ship

PLACE

Year

ESO:Short term in-house observer ship

The Royal Marsden Hospital, London UK

2019

ASH: Short term in-house observer ship

Sarah Cannon Center, Nashville, USA

2017

MASTERCLASS and in house observership on BREAST CANCER

Memorial Sloan Kettering Cancer Center (MSK or MSKCC) 

2023

 

Awards/Honors

 

Year

Dronacharya-Award-Excellence in Oncology

Received by Minister of Health and welfare

2019

Golden Aim Award -Teaching

Received by Minister of Health and welfare

2020

Golden Aim Award -Research

Received by President IMA

2021

Golden Aim Award _Patient care

Received by President IMA

2023

Hans WyderAward

Ascona, Switzerland

2013

Young Investigator Award

International Society of hematology and oncology (SOHO),Texas,USA

2022

Merit Award

Asco2011 ,Chicago,usa

2011

Young Investigator and Best Poster Award

Global Breast Cancer Conference, Seoul

2020

Young Investigator award

Gi-Esmo, Barcelona

2015

Travel scholarship and Best Poster Award

Esmo , Barcelona , Spain

2019

Young investigator award

Saint Gallen Breast Cancer Conference

2013

  

ESMO PRECEPTORSHIP Place Year

Colorectal Cancer

Prague

6-7 July 2016

Immuno-Oncology

Amsterdam,

30 September – 1 October 2015

Signalling Pathways

Barcelona

13 – 14 March 2015

Non-Small Cell Lung Cancer

Copenhagen

7-8 July 2015

GI Neuroendocrine tumors

Singapore

2-3 November 2012

  

International Oncology Research scholarship/grant

PLACE

Year

American Association of Cancer Research (AACR)/Australia & Asia Pacific Clinical Oncology Research Development (ACORD)

Sydney, Australia

2018

INDOX Cancer Research Network 

University of Oxford, United Kingdom ( UK)

2012

European Society Of Medical Oncology (ESMO)- Translational unit visit

Christie NHS Foundation Trust, Manchester, United Kingdom ( UK)

2012

European School of Oncology –Master class in clinical Oncology

Ermatingen, Switzerland

2012

 

Miscellaneous

Principal Investigator: projects -3 ( active ) , total =9

DM ( Medical Oncology ) and DNB Examiner in different hospitalssince 2019

CLINICAL PROJECT – AS A CO- INVESIGATOR with Different super/sub specialties in AIIMS (40 in number)

Setting up Hospital Based Cancer Registries ( HBCRs) and Pattern of Care and Survival Studies on Breast Cancer

DM-Medical Oncology Teaching curriculum & Exam Coordinator: between 2013-2022

Expert member in Executice commetie of Ethics at Safderjang Hospital, New Delhi

Active participation in teaching including MBBS/MD/DM/ MSc Nursing Student

Active Participation in Annual Free Medical Camp organized by AIIMS and Govt. of India at LEH, DHARAMSHALA, Jhanskar,Tawang (Arunachal Pradesh) and MUNGDOD Hubli

Regular Participating in patient awareness programme in DOORDARSHAN, DD news & RAJSABHA TV

 

 CURRENT MEMBERSHIPS IN PROFESSIONAL SOCIETIES

  • Members in American Society of Clinical Oncology-(ASCO ID -10476)

  • European Society of Medical Oncology- ESMO-ID-(82716)

 

PUBLICATIONS: over 400(Name Highlighted)

  • Yadav MP, Ballal S, Martin M, Roesch F, Satapathy S, Moon ES, Tripathi M, Gogia A.Bal C. Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment. Eur J Nucl Med Mol Imaging. 2024 Feb;5 1(3):805-819. doi: 10.1007/s00259-023-06482-z. Epub 2023 Nov 7. PMID: 37932560.

  • Chatzikonstantinou T, Scarfò L, Karakatsoulis G, Minga E, Chamou D, Iacoboni G, Kotaskova J, Demosthenous C, Smolej L, Mulligan S,Alcoceba M, Al-Shemari S, Aurran-Schleinitz T, Bacchiarri F, Bellido M, Bijou F, Calleja A, Medina A, Khan MA, Cassin R, Chatzileontiadou S, Collado R, Christian A, Davis Z, Dimou M, Donaldson D,Santos GD, Dreta B, Efstathopoulou M, El-Ashwah S, Enrico A,Fresa A, Galimberti S, Galitzia A, García-Serra R, Gimeno E, González-Gascón-Y-Marín I, Gozzetti A, Guarente V, Guieze R, Gogia A.et al .Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY. EClinicalMedicine. 2023 Nov 15; 65:102307.doi: 10.1016/j.eclinm.2023.102307. PMID: 38033506; PMCID: PMC10685149.

  • Kumar R, Kumar R, Goel H, Kumar S, Ningombam SS, Haider I, Agrawal U, Deo S, Gogia A.Batra A, Sharma A, Mathur S, Ranjan A, Chopra A, Hussain S, Tanwar P. Whole exome sequencing identifies novel variants of PIK3CA and validation of hotspot mutation by droplet digital PCR in breast cancer among Indian population. Cancer Cell Int. 2023 Oct 11;23(1):236. doi: 10.1186/s12935-023-03075-6. PMID: 37821962; PMCID: PMC10568783.

  • Sharma RK, Gogia A.Deo S, Sharma D, Mathur S, Sagiraju HKR. Dose-dense neoadjuvant chemotherapy in triple-negative breast cancer: Real-world data from a developing country. Indian J Cancer. 2023 Oct 1; 60(4):505-511.doi: 10.4103/ijc.ijc_1120_21. Epub 2024 Jan 4. PMID: 38189648.

  • Paikaray SK, Gogia A.Kumar L, Sharma A, Biswas AA, Vishnubhatla S, Mallick S. A Phase III open-label randomized study to compare the efficacy of lenalidomide-rituximab with bendamustine-rituximab in treatment-naïve follicular lymphoma. Indian J Cancer. 2023 Oct 1; 60(4):501-504.doi: 10.4103/ijc.IJC_633_20. Epub 2024 Jan 4. PMID: 38185869.

  • Kashyap A, Umar SM, Dev J R A, Mathur SR, Gogia A.Batra A, Deo SVS, Prasad CP. Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysis. J Cell Biochem. 2023 Sep;12 4(9):1259-1272. doi: 10.1002/jcb.30443. Epub 2023 Jul 14. PMID: 37450687.

  • Sahu MK, Singh SP, Satsangi A, Gogia A.Hote MP, Seth S. Posttransplant lymphoproliferative disorder in a heart transplant recipient:a case report. Indian J Thorac Cardiovasc Surg. 2023 Sep;39(5):535-538. doi: 10.1007/s12055-023-01524-5. Epub 2023 Jun 14. PMID: 37609612; PMCID: PMC10441853

  • Gupta A, Gogia A.Deo S, Sharma DN, Mathur S, Sagiraju HKR. Neoadjuvant chemotherapy with or withoutanthracyclines in combination with single HER2-targeted therapy in HER2-positive breast cancer. Cancer Treat Res Commun. 2023;36:100741. doi: 10.1016/j.ctarc.2023.100741. Epub 2023 Jul 9. PMID: 37453371.

  • Pandey P, Sharma A, Gogia A.Bone health in breast cancer. Curr Probl Cancer. 2023 Jun;47(3):100959. doi: 10.1016/j.currproblcancer.2023.100959. Epub 2023 May 5. PMID: 37236055.

  • Sharma V, Kumar A, Baa A, Kirar S, Sharma A, Bakhshi S, Gogia A.Malik PS, Rastogi S, Batra A, Pushpam D, Kataria B, Sagiraju H, Sharma A, Singh V. Dexamethasone-free antiemetic strategy for highly emetogenic chemotherapy: safety and efficacy-pilot study.BMJ Support Palliat Care. 2023 Mar 16:spcare-2022-003864. doi: 10.1136/spcare-2022-003864. Epub ahead of print. PMID: 36927873.

  • Sg N, Gogia A.Sacituzumab Govitecan in Hormone Receptor-Positive Metastatic Breast Cancer. J Clin Oncol.2023 Mar 10;41(8):1631. doi: 10.1200/JCO.22.02113. Epub 2023 Jan 6. PMID: 36608301.

  • Mishra A, Oberoi AS, Deo S, Sharma J, Gogia A.Sharma DN, Mathur S, Dhamija E. Bilateral Breast Cancer: Clinical Profile and Management. Indian J Surg Oncol. 2023 Sep;14(3):651-658. doi: 10.1007/s13193-023-01731-x. Epub 2023 Mar 7. PMID: 37900630; PMCID: PMC10611650.

  • Jain S, Goswami A, Lone MR, Ramteke P, Gogia A.Aggarwal M, Viswanathan GK, Kakkar D, Mandal T, Sharma A, Sahoo R, Baldia A, Sharma MC, Bakhshi S, Pramanik R, Dhawan R, Kumar L, Mallick S.Follicular Helper T-Cell-derived Nodal Lymphomas: Study of Histomorphologic, Immunophenotypic, Clinical, and RHOA G17V Mutational Profile. Appl Immunohistochem Mol Morphol. 2023 Mar 1;31(3):172-180. doi: 10.1097/PAI.0000000000001105. Epub 2023 Feb 20. PMID: 36806188.

  • Taneja N, Dev T, Patel U, Arava S, Gogia A.Gupta V. Rapidly progressive hyperpigmented keratotic plaques with epidermotropism. Indian J Dermatol VenereolLeprol. 2023 Jan-Mar;8 9(2):283-286. doi: 10.25259/IJDVL_1200_20. PMID: 34379962.

  • Mansouri L, Thorvaldsdottir B, Sutton LA, Karakatsoulis G, Meggendorfer M, Parker H, Nadeu F, Brieghel C, Laidou S, Moia R, Rossi D, Catherwood M, Kotaskova J, Delgado J, Rodríguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarfo L, Mattsson M, Davis Z, Gogia A.et al Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.Leukemia. 2023 Feb;37(2):504.

  • Mansouri L, Thorvaldsdottir B, Sutton LA, Karakatsoulis G, Meggendorfer M, Parker H, Nadeu F, Brieghel C, Laidou S, Moia R, Rossi D,Catherwood M, Kotaskova J, Delgado J, Rodríguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarfo L, Mattsson M, Davis Z, Gogia A.et al Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status:a study by ERIC in HARMONY. Leukemia. 2023 Feb;37(2):504. doi: 10.1038/s41375-023-01813-3. Erratum for: Leukemia. 2023 Feb;37(2):339-347. PMID: 36635392; PMCID: PMC9898025.

  • Pandey P, Kumar A, Pushpam D, Khurana S, Malik PS, Gogia A.Arunmozhimaran E, Singh MB, Chandran DS, Batra A. Randomized double-blind, placebo-controlled study of oral gabapentin for prevention of neuropathy in patients receiving paclitaxel. Trials. 2023 Feb 3;24(1):79. doi: 10.1186/s13063-023-07126-1. PMID: 36732774; PMCID: PMC9896696

  • Mansouri L, Thorvaldsdottir B, Sutton LA, Karakatsoulis G, Meggendorfer M, Parker H, Nadeu F, Brieghel C, Laidou S, Moia R, Rossi D, Catherwood M, Kotaskova J, Delgado J, Rodríguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarfo L, Mattsson M, Davis Z, Gogia A.et al. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia. 2023 Feb;37(2):339-347. doi: 10.1038/s41375-022-01802-y. Epub 2022 Dec 24.Erratum in: Leukemia. 2023 Jan 12;: PMID: 36566271; PMCID: PMC9898037.

  • Dhar A, Srivastava A, Pandey RM, Shrestha P, Villet S, Gogia A.Safety and Efficacy of a Mobiderm Compression Bandage During Intensive Phase of Decongestive Therapy in Patients with Breast Cancer-Related Lymphedema: A Randomized Controlled Trial.Lymphat Res Biol. 2023 Feb;21(1):52-59.

  • Rana R, Ranjan V, Kumar N, Chugh P, Khillan K, Gogia A.Rana DS, Ganguly NK.
    Association of underlying comorbidities and progression of COVID-19 infection amongst 2586 patients hospitalised in the National Capital Region of India: a retrospective cohort study.
    Mol Cell Biochem. 2023 Jan;478(1):149-160.

  • Ganguly S, Gogia A.Overall survival with osimertinib in resected EGFR-mutated non-small-cell lung cancerCancer Research, Statistics, and Treatment 6 (4) (2023), 640-641

  • Pandey P, Gogia A.Fifteen-year outcomes in prostate cancerCancer Research, Statistics, and Treatment 6 (4) (2023), 635-636

  • Mane P, Ramteke P, Singh A, Gogia A.Mallick S,Primary extranodal NK/T cell lymphoma of stomach: A case report and review of literature Indian Journal of Pathology and Microbiology, (2023)10.4103

  • Pandey P, Gogia A.Time to question extended adjuvant endocrine therapy for allCancer Research, Statistics, and Treatment 6 (4),(2023) 636-637

  • Ganguly S, Gogia A.Perioperative nivolumab and chemotherapy in resectable Stage III non-small-cell lung cancerCancer Research, Statistics, and Treatment 6 (2023)(4), 643

  • Ganguly S, Gogia A.Omitting radiation in early-stage breast cancerCancer Research, Statistics, and Treatment 6 (2023)(4), 642-643

  • Pandey P, Gogia. AVeneto clax in chronic lymphocytic leukemiaCancer Research, Statistics, and Treatment 6 (2023) (4), 638

  • Ganguly S, Gogia A. Capivasertib in advanced hormone receptor-positive breast cancerCancer Research, Statistics, and Treatment 6 (2023)(4), 633

  • Pandey P, Gogia A. Sacituzumab govitecan: A narrative drug reviewCancer Research, Statistics, and Treatment 6 (4)(2023), 562-572

  • Ganguly S, Gogia A.Preoperative treatment in locally advanced rectal cancerCancer Research, Statistics, and Treatment 6 (4)(2023), 641-642

  • Ganguly S, Gogia A. Pembrolizumab in advanced endometrial cancerCancer Research, Statistics, and Treatment 6 (4)(2023), 631-632

  • R Pramanik, S Vats, S Mitra, SVS Deo, L Kumar, Gogia. A, Khurana S,et al Assessment of Knowledge and Attitude of Breast and Ovarian Cancer Patients Regarding Hereditary Breast-Ovarian Cancer Syndrome at a Tertiary Cancer Institute: A Cross-Sectional studyIndian Journal of Medical and Paediatric Oncology 2023

  • Pandey P, Gogia A.Sequencing therapies for metastatic hormone receptor-positive breast cancerCancer Research, Statistics, and Treatment (2023)6 (4), 639

  • Pandey P, Gogia A. Anthracycline-and taxane-containing chemotherapy for early-stage breast cancer, Cancer Research, Statistics, and Treatment 6 (4) (2023), 633-634

  • Pandey P, Gogia A. Protocol amendment in clinical trialsCancer Research, Statistics, and Treatment 6 (4)(2023), 645

  • Ganguly S, Gogia A. Perioperative pembrolizumab in early-stage non-small-cell lung cancerCancer Research, Statistics, and Treatment 6 (4)(2023), 644

  • Pandey P, Gogia A. Empowering breast cancer survivors: Nurturing self-compassion for a positive body image Cancer Research, Statistics, and Treatment 6 (4) (2023), 581-583

  • Pandey P, Gogia. A Cabozantinib plus nivolumab and ipilimumab in renal cell carcinomaCancer Research, Statistics, and Treatment 6 (4)(2023), 635

  • Ganguly S, Gogia A. Dostarlimab in recurrent endometrial cancerCancer Research, Statistics, and Treatment 6 (4)(2023), 632

  • Upadhya S, Gogia A. Interrupting endocrine therapy in hormone-positive early breast cancerCancer Research, Statistics, and Treatment 6 (4), (2023) 639-640

  • Pandey P, Gogia A. Rucaparib in metastatic prostate cancerCancer Research, Statistics, and Treatment 6 (2) (2023), 360-361.

  • Chib S, Gogia.A Apatinib plus pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer Cancer Research, Statistics, and Treatment 5 (4), 793-794 (2023)

  • Pandey P, Gogia A. Neoadjuvant pembrolizumab in advanced melanoma Cancer Research, Statistics, and Treatment 6 (2)(2023), 360

  • Mallick S, Pandey P, Gogia A. Breast-conserving surgery without irradiation in early breast cancer ,Cancer Research, Statistics, and Treatment 6 (2)(2023), 361-362

  • Oberoi AS, Deo SVS, Bhoriwal S, Sharma DN, Gogia.A, Mathur S.Treatment patterns in breast cancer: Real world data audit from tertiary care cancer center in LMICEuropean Journal of Surgical Oncology 49 (5) 2023, e230-e231

Recently accepoted

  • A Mishra, AS Oberoi, S Deo, J Sharma, A.Gogia, DN Sharma, S Mathur, Bilateral Breast Cancer: Clinical Profile and Management Indian Journal of Surgical Oncology 2023 , 1-8

 

POSTER / ORAL PRESENTATION – abstracts

  • I Gupta, MR Lone, P Ramteke, A.Gogia Upadhyay, S Mallick Poster: ABCL-523 Immunohistochemical (IHC) Expression of Epigenetic Regulators (EZH-2 and H3K27) as well as Cell Cycle Regulators (P16, P53 and RB) Clinical Lymphoma, Myeloma and Leukemia 2022, S170

  • I Gupta, MR Lone, P Ramteke, A.Gogia, A Upadhyay, S Mallick, ABCL-523 Immunohistochemical (IHC) Expression of Epigenetic Regulators (EZH-2 and H3K27) as well as Cell Cycle Regulators (P16, P53 and RBClinical Lymphoma Myeloma and Leukemia 2022, S382

  • A.Gogia, R Gupta, L Kumar, A Sharma, L Rani, S MallickIBCL-429 Prevalence of B-Cell Chronic Lymphoproliferative Disorders at a Large Tertiary Care Center in IndiaClinical Lymphoma Myeloma and Leukemia 2022, S392

  • Bharath BG, A.Gogia. Smart start: It really is SMART!Cancer Research, Statistics, and Treatment 5 (4), 795-796 (2022)

  • Jain S , Mandal T,Ramteke P, Sharma MC, A. Gogia, M Aggarwal, ...Poster: TCL-306 Application of the Proposed Immunohistochemistry Algorithm for the Prognostication of GATA3 and TBX21 Subtypes of Peripheral T-Cell Lymphoma, Not Otherwise …Clinical Lymphoma, Myeloma and Leukemia (2022), S176

  • J Ghosh, C Das, A.Gogia, G Biswas, C Desai, S Rajpurohit, P Mehta, ...EP216/# 881 Safety and tolerability of olaparib in Indian patients with ovarian cancer: the prospective, single-arm, phase 4 soli trial International Journal of Gynecologic Cancer (2022) 32 (Suppl 3)

  • Gupta A, A.Gogia, Sagiraju HK, Deo SV, Gupta R, Mathur S, Sharma D. A real-world experience of TCH (docetaxel/carboplatin/trastuzumab) regimen in early, locally advanced and oligometastatic HER2 positive breast cancer from tertiary care center in North India. J Clin Oncol 2022;40:e12505-e12505 .

  • A.Gogia, Gupta A, Deo SV, Sharma D, Mathur S. Safety, efficacy and survival outcome of Ado-trastuzumab emtansine (T-DM1) in patients with metastatic HER2-positive breast cancer: An Indian experience. J Clin Oncol 2022;40:e13008-e13008.

  • Sharma RK, A.Gogia, Sagiraju HK, Deo SS, Sharma D, Mathur S. Impact of capecitabine maintenance on survival outcomes in triple-negative breast cancer patients not attaining pathological complete response following neoadjuvant chemotherapy: Real-world data from a tertiary care center from India. J Clin Oncol 2022;40:e12593-e12593.

  • Batra A, kumar A, Pramanik R, Khurana S, Pushpam D, Bakhshi S, Sharma A, A.Gogia, Malik PS. Physical and psychological symptom burden in patients newly diagnosed with solid organ cancers in a tertiary care centre in India. J Clin Oncol 2022;40:e24081-e24081.

  • Sagiraju HK, A.Gogia, Sharma RK, Deo SV, Sharma D, Gupta R, Mathur S. Association of pre-treatment hemoglobin levels with survival outcomes among Indian women with triple negative breast cancer. J Clin Oncol 2022;40:e12549-e12549

  • Gupta A, A.Gogia, Sagiraju HK, Deo SV, Sharma D, Mathur S, Gupta R. Outcomes of neoadjuvant combination chemotherapy with and without targeted therapy in HER2-positive breast cancer: A real-world experience from tertiary care center in North India. J Clin Oncol 2022;40:e12601-e12601 .

  • A.Gogia, Sharma A, Gupta R, Rani L, Mallick S. Safety and efficacy of Ibrutinib in Indian patients with chronic lymphocytic leukemia. J Clin Oncol 2022;40:e19585-e19585

  • Das N, Gupta R, Dahiya M, Rai S, Singh S, Sahoo RK, A.Gogia, Sharma A, Kumar L. MM-359: Pattern-Based Identification of Normal and Aberrant Plasma Cell Compartment across a Spectrum of Plasma Cell Proliferative Disorders Using Multiparametric Flow Cytometry. Clinical Lymphoma Myeloma and Leukemia. 2021 Sep 1;21:S438.

  • S Jain, A Goswami, T Mandal, MR Lone, P Ramteke, MC Sharma A.Gogia....Poster: TCL-239: Clinical, Pathological, and Prognostic Implications of RHOAG17V Mutation in Peripheral T-Cell Lymphomas Clinical Lymphoma Myeloma and Leukemia 2021, S248

  • DN Sharma, SVS Deo, S Bhoriwal, Y Izzuddeen, A Binjola, A. Gogia :-MSPP04 Presentation Time: 4: 30 PM: Interstitial Brachytherapy Based Accelerated Partial Breast Irradiation After Oncoplastic Breast Conserving SurgeryBrachytherapy 2021 (6), S36

  • N Das, R Gupta, M Dahiya, S Rai, S Singh, RK Sahoo, A.Gogia, A Sharma, ... MM-359: Pattern-Based Identification of Normal and Aberrant Plasma Cell Compartment across a Spectrum of Plasma Cell Proliferative Disorders Using Multiparametric Flow Cytometry Clinical Lymphoma Myeloma and Leukemia 2021, S438

  • A.Gogia, S Chellapuram, A Sharma, S Mallick, R Gupta, ABCL-064:“DA-EPOCH+/-R” Protocol in High-Grade Lymphoma: An AnalysisClinical Lymphoma Myeloma and Leukemia 2021 , S379-S380

  • R Gupta, N Das, M Dahiya, S Rai, S Singh, VK Prajapati, A.Gogia...MM-329: Evaluation of Immunophenotype of the Non-Neoplastic Plasma Cell Compartment and Post-Therapy Immunomodulation to Understand Nuances in MRD Assessment of Multiple …Clinical Lymphoma Myeloma and Leukemia 2021, S436-S437

  • P Ramteke, S Jain, S Meena, T Mandal, P Das, R Yadav, MC Sharma, A. Gogia:- ...Poster: ABCL-321: Clinicopathological Profile of Gastrointestinal Lymphoma Diagnosed Over a Period of 6-Years: A Tertiary Care Center ExperienceClinical Lymphoma Myeloma and Leukemia 2021, S242

  • A. Gogia, Kumar L, Sharma A, Mallick S, Gupta R, Rani L. CLL-069: Incidence of Second Cancer in Patients with Chronic Lymphocytic Leukemia: The Indian Scenario. Clinical Lymphoma, Myeloma and Leukemia. 2021 Sep 1;21:S316-7.

  • Jain S, Goswami A, Mandal T, Lone MR, Ramteke P, Sharma MC, A. Gogia , Sharma A, Aggarwal M, Sahoo R, Bakhshi S. TCL-239: Clinical, Pathological, and Prognostic Implications of RHOAG17V Mutation in Peripheral T-Cell Lymphomas. Clinical Lymphoma, Myeloma and Leukemia. 2021 Sep 1;21:S413-4.

  • Sharma RK, A. Gogia Deo SV, Sharma D, Mathur S, Sagiraju HK. Does pathological complete remission after neoadjuvant chemotherapy translate to longer relapse-free survival in patients with triple-negative breast cancer in the Indian population? J Clin Oncol. 2021;39:e12618-e12618.

  • Sagiraju HK, A. Gogia Sharma D, Deo SV, Mathur S. Survival outcomes of breast cancer patients with brain metastases: Single center experience from Northern India. J Clin Oncol. 2021 39:15_suppl, e13003-e13003

  • A. Gogia Arora S, Choudhary P, Kumar R, Thulkar S, Deo SV, Sharma D, Bhatnagar S. Real-world Indian scenario of CDK4/6 inhibitors (palbociclib and ribociclib) with endocrine therapy in upfront hormone positive metastatic breast cancer. J Clin Oncol 2021 39:15_suppl, e13028-e13028.

  • A. Gogia, Arora S, Deo SV, Mathur S, Sharma D. Efficacy and safety of neoadjuvantdocetaxel, carboplatin, trastuzumab, and pertuzumab (TCH-P) in HER2-positive breast cancer: An Indian experience. J Clin Oncol. 2021 39:15_suppl, e12619-e12619 Sharma RK, A.GOGIAGupta R, Deo SV, Sharma D, Mathur S, Sagiraju HK. Impact of pre-treatment derived neutrophil-lymphocyte-ratio on outcomes in patients with triple- negative breast cancer. J Clin Oncol 2021 39:15_suppl, e12556-e12556.

  • Atul Batra, Akhil P. Santosh, Raja Pramanik, A. Gogia, R. M. Pandey, akashkumar, Atul SharmaRandomized double-blind, placebo-controlled study of topical diclofenac in prevention of hand-foot syndrome in patients receiving capecitabine. (ASCO 2021) J Clin Oncol 39, 2021 (suppl 15; abstr TPS12135)

  • Rakesh Kumar Sharma, A. Gogia, SVS Deo, Dayanand Sharma, Sandeep Mathur, Hari Krishna Raju Sagiraju;Impact of pre-treatment derived neutrophil-lymphocyte-ratio on outcomes in patients with triple-negative breast cancer. J Clin Oncol 39, 2021 (suppl 15; abstr e13010)

  • K Raghuram, SVS Deo, A. Gogia, S Thulkar, E Dhamija, DN Sharma, Analysis of surgical and oncological outcomes of breast conservation surgery following neo adjuvant chemotherapy in locally advanced breast cancer. European Journal of Surgical Oncology 46 2021(6), e31

  • SC Nair, A. Gogia, L Kumar, A Sharma, A Biswas, S Mallick :-Clinicopathological features and outcome of diffuse large B-cell lymphoma patients treated in a resource-limited setting.Journal of Clinical Oncology 38 (15_suppl), e20062-e20062

  • A. Gogia, S Nair, A Sharma, L Kumar, S Mallick, A Biswas, R Gupta Non-Hodgkin lymphoma: The Indian scene. Journal of Clinical Oncology 38 (15_suppl), e20063-e20063

  • A. Gogia, S Deo, D Sharma, S Mathur. Breast cancer: The Indian scenario.Journal of Clinical Oncology 38 (15_suppl), e12567-e12567

  • SC Nair, A. Gogia, L Kumar, A Sharma, A Biswas, S Mallick Clinicopathologic features and outcome of extra-nodal diffuse large B-cell lymphoma: An institutional experience from North India.Journal of Clinical Oncology 38 (15_suppl), e20079-e20079

  • P Choudhary, A. Gogia, S Deo, S Mathur, D Sharma. Neoadjuvant chemotherapy in locally advanced breast cancer: Clinicopathological characteristics and correlation with pathological complete response.Journal of Clinical Oncology 38 (15_suppl), e12658-e12658

  • R Gupta, L Rani, G Kaur, S Khan, A. Gogia ,A Gupta, A Sharma, L KumarmiR-223 and miR-551a as gene signatures of aggressive chronic lymphocytic leukemia. Leukemia& Lymphoma 61, 206-207

  • S Mathur, A Johnson, SVS Deo, A. Gogia, S Kahol, D Jain, V IyerPDL1 Expression and Tumour Infiltrating Lymphocytes in Triple-Negative Breast Cancer and its Correlation with Clinicopathological Features and Response to ChemotherapyLaboratory Investigation 100 (Suppl 1), 208-209

  • H Natarajan, L Kumar, S Bakhshi, A Sharma, T Velpandian, M Kabra, A. Gogia Imatinib induced toxicity and its influence on cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia Annals of Oncology 201930 (Supplement_9), mdz427. 004

  • A. Gogia L Kumar, A Sharma, R Gupta, L Rani. Incidence and outcome of chronic lymphocytic leukemia with deletion 17p: An Indian experience; challenges and opportunities. Annals of Oncology 30 (Supplement_5), mdz269. 055

  • N Das, A Malhotra, R Gupta, S Rai, SK Gupta, RK Sahoo, A. GogiaCD123 is an Important Predictor of Post Induction Response and Early Treatment Outcome in Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma and Leukemia 19, S197

  • S Mallick, A Panda, MR Lone, A Goswami, P Ramteke, MC Sharma, A. GogiaClinicopathologicalProfileof Primary Double Expressor Lymphoma. Clinical Lymphoma, Myeloma and Leukemia 19, S257

  • N Das, A Malhotra, R Gupta, S Rai, S Singh, RK Sahoo, A. Gogia.Role of CD123 as Determinant of Minimal Residual Disease in Acute Myeloid Leukemia. Clinical Lymphoma, Myeloma and Leukemia 19, S235

  • A. Gogia, R Gupta, A Sharma, L Kumar, V Raina, L Rani. Chronic lymphocytic leukemia: An Indian experience. Journal of Clinical Oncology 37 (15_suppl), e19007-e19007 2019

  • KR Soti, L Kumar, R Saxena, S Bakhshi, A. Gogia, PS Malik, R Sahoo. Characteristics and outcomes of Philadelphia chromosome-negative myeloproliferative neoplasm in a tertiary institute in India: An ambispective study. Journal of Clinical Oncology 37 (15_suppl), e18553-e185532019

  • M Sharma, A. Gogia SVS Deo, NK Shukla, S Thulkar, R Kumar, D SharmaProfile of metastatic breast carcinoma: Single center experience from a developing country. Journal of Clinical Oncology 36 (15_suppl), e13102-e13102……2018

  • M Sharma, A. Gogia SVS Deo, NK Shukla, D Sharma, S Thulkar, R KumarEstrogen receptor (ER), progesterone receptor (PR) and Her2neu receptor expresssion: Change from baseline to first metastasis in breast cancer—Single center experience from … Journal of Clinical Oncology 36 (15_suppl), e13095-e1309, 2018

  • SK Paikaray, A. Gogia L Kumar, A Sharma, A Biswas, MC SharmaA phase III open label randomized study to compare the efficacy of lenalidomide-rituximab vs bendamustine-rituximab in treatment naive follicular lymphoma. Journal of Clinical Oncology 36 (15_suppl), e19552-e19552…….2018

  • A Biswas, L Kashyap, N Adhikari, A. Gogia, R Sahoo, A Sharma. Secondary central nervous system lymphoma clinical experience from a regional cancer centre in India. Radiotherapy and Oncology 127, S692…2018

  • L Rani, M Dahiya, N Mathur, R Gupta, A. Gogia, L Kumar, A Sharma.Detection of genetic aberrations in CLL using multiplex ligation-dependent probe amplification (MLPA).Leukemia & Lymphoma 58, 176-177..2017

  • SVS Deo, NK Shukla, A. GogiaBilateral Breast Cancer-Incidence, Clinical Spectrum And Challenges In The Management.. Journal of Cancer Research & Therapeutics 13. 2017

  • SVS Deo, NK Shukla, A. Gogia, Criteria For Pathological Complete Response (Pcr) Cr And Its Impact On Relapse Rates In Breast Cancer Patients Undergoing Neo-Adjuvant Chemotherapy- Journal of Cancer Research & Therapeutics 13. 2017

  • L Rani, R Gupta, N Mathur, K Singh, A. Gogia, D Sundar, L Kumar,Elucidation of miRNAs associated with disease progression and response in chronic lymphocytic leukemia, et.al. LEUKEMIA & LYMPHOMA 58, 173-174….2017

  • A Jakhetiya, SS Deo, NK Shukla, A. Gogia D Sharma, D Muduly, S Mathur ,Patterns of Loco-Regional Relapse in Curatively Treated Locally Advanced Breast Cancer (LABC) Patients: A Single Centre Retrospective Study. et.al. Annals Of Surgical Oncology 24, S50-S50…2017

  • VG Gupta, A. GogiaP Mehta, L Kumar, A Sharma, S Bakhshi, S Thulkar.Early stage natural killer/T cell lymphoma with local tumor invasiveness treated with a uniform SMILE protocol: An institutional study from India. Annals of Oncology 27 (suppl_9)..2016

  • S Bhoriwal, S Deo, R Kumar, NK Shukla, S Thulkar, A. Gogia DN Sharma,A prospective study comparing conventional investigation and PET-CT scan for staging in locally advanced breast carcinoma. et.al. European journal of Surgical Oncology Volume 42,Issue 42, Issue 9, Pages S138

  • CK Das, L Kumar, A. Gogia R Kaushal.Bone marrow involvement in mantle cell lymphoma: An immunophenotyping analysis with clinicopathologic correlation from a tertiary care center in North India.European Journal of Surgical Oncology 42 (9), S138..2016

  • S Taywade, R Kumar, A Behera, N Damle, M Tripathi, A. Gogia CS Bal.Role of 18F-FDG PET/CT in the management of patients with primary breast lymphoma.Journal of Clinical Oncology 34 (15_suppl), e19073-e19073

  • L Kumar, RR Boya, R Pai, B Sainath, RK Sahoo, PS Malik, A Mookerjee, A. GogiaAutologous stem cell Transplantation (ASCT) for Multiple Myeloma (MM): Predictors of long term outcome. Journal of Nuclear Medicine 57 (supplement 2), 1623-1623…2016

  • A Singh, S Purkait, A. Gogia, S Mallick.Non-Hodgkin lymphoma unclassifiable between diffuse large B-cell lymphoma and Burkitt lymphoma. Clinical Lymphoma, Myeloma and Leukemia 15, e146-e147

  • R Gupta, L Rani, N Mathur, A. Gogia D Sundar, A Sharma, L Kumar. Impact of DNA methylation and gene expression profile on treatment initiation and treatment free survival in early stage CLL.Clinical Lymphoma, Myeloma and Leukemia 15, e145-e146

  • RR Boya, S Bakhshi, A. Gogia RK Sahoo, L Kumar. Prediction of poor mobilization of Peripheral Blood Stem Cells (PBSC) with G-CSF alone, in multiple myeloma (MM) patients undergoing autologous transplantation.Clinical Lymphoma, Myeloma and Leukemia 15, 171-72

  • P Mehta, V Raina, L Kumar, A Sharma, S Bakhshi, A. Gogia T Tvsvgk.Nasal NK-T cell lymphoma: 10-year experience of a single institute in India.Journal of Clinical Oncology 32 (15_suppl), 19536

  • S Mallick, MR Lone, P Ramteke, S Purokait, A. Gogia. ClinicoPathological Profile And Cmyc Immunoreactivity Of Alk Positive Large B Cell Lymphoma: Report Of Nine Cases Hematological Oncology Volume 35, Issue S2,Page 395-6

  • Ritu Gupta, Lata Rani, NitinMathur, A. Gogia ADuraiSundar, Atul Sharma, Lalit Kumar.Impact of DNA methylation and gene expression profile on treatment initiation and treatment free survival in early stage CLL. Journal of Clinical Oncology 33 (15_suppl), e22073- e22073

  • SK Bhoriwal, SVS Deo, NK Shukla, P Garg, R Kumar, A. Gogia DN Sharma, S Thulkar, S Mathur. 18FDG PET-CT–SUV correlation with molecular subtypes in locally advanced/recurrent breast carcinoma Hematological Oncology Volume 35, Issue S2, Pages, 395-396

  • Pankaj Kumar Garg, SV SuryanarayanaDeo, Rakesh Kumar, Nootan Kumar Shukla, Sanjay Thulkar, A. Gogia , Dayanand Sharma, Sandeep R Mathur. Role of FDG PET–CT (Positron Emission Tomography and Computed Tomography) scan in the staging of locally advanced/recurrent breast cancer as a single modality.. Journal of Clinical Oncology Volume 33 e11508Publisher American Society of Clinical Oncology

  • CK Das, A Garg, A. Gogia, 533P Docetaxel induced cutaneous toxicity in breast cancer patients.(2016) (Annals of Oncology Volume 27Issuesuppl_9)

  • Prashant Mehta, VinodRaina, Lalit Kumar, Atul Sharma, Sameer Bakhshi, A. Gogia, TilakTvsvgk, BivasBiswas, SiddharthSahai, Surendra Pal Chaudhary, Vijay Murugan, Mehar C Sharma, SandeepMathur, Sanjay Thulkar. Nasal NK-T cell lymphoma: 10-year experience of a single institute in India.Journal of Clinical Oncology Volume 32Issue 15_suppl Pages e19536 Publisher American Society of Clinical Oncology

  • C.K. Das, A. Gogia, N.K. ShuklaS. DeoS. MathurD. SharmaPrognostic significance of the derived neutrophil lymphocyte ratio in metastatic breast cancer: A tertiary cancer care center analysis from India. Annals of Oncology, Volume 27, Issue suppl_9, 1 December 2016, mdw577.005,

  • Natarajan H, Lalit Kumar, Sameer Bakhshi, Atul Sharma, Madhulika K, Velpandian T, A. Gogia, ShivaramShastri, Yogendra Kumar Gupta. Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in patients with chronic myeloid leukemia.Cancer Research Volume76 Issue14 Supplement Pages2040-2040 Publisher American Association for Cancer Research

  • Reddy R, Sharma A, Bakhshi S, A. Gogia, Sahoo R, Yadav CP, Kumar L. Comparison of three leukapharesis machines for harvest of stem cells for autologous transplantation: A prospective study.Journal Of Clinical Oncology 34(15_Suppl) 8024

  • H Natarajan, L Kumar, S Bakhshi, A Sharma, T Velpandian, A. Gogia, K Gupta. Imatinib trough levels: A potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia. Annals of Oncology Volume 27 Issue suppl_9 Page 586

  • P Mehta, L Kumar, V Raina, A Sharma, S Bakhshi, A. Gogia RK Sahoo, S Pabbi, A Chopra, R Kumar high dose (18 g/m) versus low dose (12 g/m) cytosine arabinoside as consolidation for acute myeloid leukemia. Annals of Oncology 26,85

  • CK Das, L Kumar, SR Mallick, A. GogiaPrognostic significance of monocyte-lymphocyte ratio in mantle cell lymphoma.Annals of Oncology.2015; Volume 26 Issue suppl_9

  • Ritu Gupta, Lata Rani, NitinMathur, A. Gogia, SreenivasVishnubhatla, Lalit Kumar, Atul Sharma, DivyaDubey, PunitKaur. Analysis of IGHV-DJ gene rearrangement and B-cell receptor stereotypes in chronic lymphocytic leukemia: an Indian study. Leukemia & Lymphoma.2015; Volume 56 Pages 124-125

  • R Upadhyay, DN Sharma, AK Gandhi, K Haresh, S Deo, A. GogiaRole of radiation therapy and its impact on survival of male breast cancer patients: experience from a tertiary cancer center. International Journal of radiation Oncology.biology.Physics.2016; 96(2)E 29

  • R Reddy, S Bakhshi, A Sharma, R Sahoo, A. Gogia PS Malik, S Iqbal, Poor mobilization of peipheral blood stem cells (PBSC) in patients undergoing autologous stem cell transplantation (ASCT): A prospective study.ClinicalLymphoma, Myeloma and Leukemia.2015; 15, e 171

  • S Gajendra, A Chopra, S Kumar, A.Gogia J Chandramohan, S Bakhshi.Immunophenotypic analysis of T-lineage acute lymphoblastic leukemia. CD5 matters.... International Journal of Radiation Oncology.2016;• Biology• Physics 96 (2), E29

  • L Kumar, P Ganess, A. Gogia I Ghosh, R Hariprasad. High Dose Chemotherapy With Autologous Stem Cell Transplantation For Multiple Myeloma: What Predicts The Outcome? Journal of Clinical Oncology.2015; 33 (15_suppl), e18013-e18013

  • A. Gogia,V Raina , Sharma MC .Survival outcome of patient with primary gastric diffuse large B-cell lymphoma: An Institutional experience from developing country.Annals of Oncology 2014 Volume26 Issue suppl 4

  • A. Gogia, V Raina, A Sharma, L Kumar, R Gupta, MC Sharma Incidence of second cancer in patients with chronic lymphocytic leukemia: 13 years experience from single institute.European Journal Of Cancer.2013; 49, S846-S846

  • A. Gogia, V Raina, A Sharma, L Kumar, R Gupta, S Gajendra, Significance of smudge cell on blood smear in chronic lymphocytic leukemia patients: A prospective single institutional study from India.European Journal Of Cancer.2013; 49, S207-S208

  • Gupta A, N Das, M Dahiya, S Rai, S Singh, VK Prajapati, Gogia A. ... Poster: MM-329: Evaluation of Immunophenotype of the Non-Neoplastic Plasma Cell Compartment and Post-Therapy Immunomodulation to Understand Nuances in MRD Assessment of …Clinical Lymphoma Myeloma and Leukemia (2021), S256

  • N Das, Gupta A, M Dahiya, S Rai, S Singh, VK Prajapati, RK Sahoo, Gogia A. :-...Poster: MM-359: Pattern-Based Identification of Normal and Aberrant Plasma Cell Compartment across a Spectrum of Plasma Cell Proliferative Disorders Using Multiparametric Flow …Clinical Lymphoma Myeloma and Leukemia (2021), S256

  • Mansouri L, Thorvaldsdottir B, Sutton LA, Meggendorfer M, Nadeu F, BrieghelC,Parker H, Laidou S, Moia R, Rossi D, Catherwood M, A.Gogia Different PrognosticImpact of Recurrent Gene Mutations in IGHV-Mutated and IGHV-Unmutated ChronicLymphocytic Leukemia: A Retrospective, Multi-Center Cohort Study By Eric, theEuropean Research Initiative on CLL, in Harmony. Blood. 2021 Nov 23;138:2617.

  • A.Gogia, A. Sharma, V. Raina, L. Kumar, R. Kumar, R. Gupta.Clinico-hematological characteristics and outcome assessment of patients with chronic lymphocytic leukemia: A single-institution study of 285 cases.DOI: 10.1200/jco.2011.29.15_suppl.6584 Journal of Clinical Oncology 29, no. 15_suppl (May 2011) 6584-6584

  • A. Gogia, Vinod Raina, Atul Sharma, Lalit Kumar, Mehar C Sharma, Ritu Gupta, Prasenjit Das.Clinical features and outcome of follicular lymphoma: 17 years experience from All-India Institute of Medical Sciences (AIIMS), New Delhi, India.Journal of Clinical Oncology Volume31 Issue15_suppl Pages e19524-e19524 American Society of Clinical Oncology 2012

  • A. Gogia,V Raina, BK Mohanti, SVS Deo, NK Shukla, V Sreeniwas.Clinical significance of triple negativity in young breast cancer patients (<= 35 years): A single-institute study from India.European Journal Of Cancer 49, S315-S315 2013

  • A. Gogia, V Raina, B Mohanti, S Deo, N Shukla Pattern and Survival of Lung Metastasis In Young Breast Cancer Patients: A Single Centre Experience Publication date2013/5/1. Journal Lung Cancer, Volume80,PagesS41, DBT -Travel Grant,Wclc, Sydney, Australia,2014

  • A. Gogia,V Raina, SVS Deo, BK Mohanti, NK Shukla, S Venkat. An overview of very young breast cancer patients. The Breast, Volume21, PagesS15,SIOP-Travel Scholarship,Dublin 2018

  • A. Gogia V Raina, SVS Deo, BK Mohanti, NK Shukla. Profile Of Male Breast Cancer: Single Institution Study Of 76 Patients from Northern India. Annals Of Oncology, Volume23, Pages110-110, young investigator award,Saintgallen Breast Cancer Conferance 2013.

  • A. Gogia, A Sharma, V Raina, L Kumar, R Gupta, R Kumar. An Overview Of Young Chronic Lymphocytic Leukemia Patients: A Single Centre Experience Of 117 Cases From Northern India Annals Of Oncology, Volume 23, Pages 358-358, ICMR-TRAVEL GRANT,ESMO-2013,Amsterdam.

  • S Roy, A Biswas, A Binjola, M Tripathi, R Kumar, S Bakhshi, R Sahoo, A. Gogia. Early Clinical Outcome, Acute Toxicity Profile And Health Related Quality Of Life After Chemo-Immunotherapy And Involved Site Radiotherapy (ISRT) In Early Nodal DLBCL-Results ..,International Journal Of Radiation Oncology, Biology, Physics.2020; 108 (3), S156-S157

  • S Jain, S Mallick, P Ramteke, A. Gogia M Agarwal, J Dass, R Yadav. Pandora Box Of Lymphomas In Spleen. ...Hematology Reports.2020; 12 (s1)

  • S Jain, A Goswami, P Ramteke, Mc Sharma, A. Gogia, A Sharma. Tcl-362: Clinicopathological Profile Of Peripheral T-Cell Lymphoma-Nos And Angioimmunoblastic T-Cell Lymphomas., ...Clinical Lymphoma, Myeloma And Leukemia.2020; 20, S256-S257

  • Ck Das, A. Gogia, L Kumar, A Sharma, S Thulkar, I Xess, K Madan. Evaluation Of Pulmonary Infiltrate In Febrile Neutropenic Patients Of Hematologic Malignancies. Indian Journal Of Medical And Paediatric Oncology.2019; 40 (03), 386-390

  • R Pramanik, H Kancharla, S Bakhshi, A Sharma, A. Gogia, P Malik.Engraftment Syndrome: A Retrospective analysis of the experience at atertiary care Institute,Clinical Hematology International.2019; 1 (2), 114

  • M Sharma, A. Gogia, Svs Deo, S Thulkar, RkPhulia, Ps Malik, S Mathur. Prognostic And Predictive Factors of Outcome In Metastatic Breast Cancer In India: Experience From A Dedicated Breast Cancer Clinic Of A Tertiary Health Care Center. The Breast.2019; 44, S61

  • A. Gogia, V Raina, S Deo, D Sharma, S Mathur. Survival Outcome Of Pregnancy Associated Breast Cancer In Resource Limited Country: An Analysis. The Breast.2019; 44, S64

  • A. Gogia, S Deo, S Mathur, D Sharma, R Gupta. Predictive Significance Of Derived Neutrophil To Lymphocyte Ratio With Neo-Adjuvant Chemotherapy In Triple Negative Breast Cancer: A Single Center Analysis. The Breast.2019; 44, S26

  • A. Gogia, V Raina, S Deo, N Shukla, B Mohanti, D Sharma, S Mathur. Neoadjuvant Chemotherapy For Young (</= 35 Years) Locally Advanced Breast Cancer Patients: Association Of Pathological Complete Response With Survival. An Institutional … The Breast. 2019; 44, S128

  • M Sharma, A. Gogia Svs Deo, S Thulkar, RkPhulia, Ps Malik, S Mathur. Oligo-Metastatic Breast Cancer: Real World Scenario From A Single Center In India. The Breast. 2019; 44, S60

  • R Singh, S Kumar, A. Gogia, D Sharma, S Deo. Impact Of Tumor Size On Prediction Of Pathological Complete Response After Neoadjuvant Chemotherapy In Breast Cancer. The Breast. 2019; 44, S70-S71

  • R Singh, S Bhoriwal, A. Gogia, D Sharma, S Deo. Routine Cavity Shave During Breast Conservation Surgery Is A Good Alternative To Frozen Sections. The Breast. 2019; 44, S110-S111

  • A Biswas, N Adhikari, A. Gogia, R Sahoo, A Garg, M Sharma, S Bhasker. High Dose Methotrexate Based Chemotherapy And Response Adapted Whole Brain Radiation Therapy In Primary Cns Lymphoma...International Journal Of Radiation Oncology, Biology, Physics. 2018; 102 (3), S192

  • N Adhikari, A Biswas, A. Gogia, A Phase II Trial Of Response Adapted Whole Brain Radiotherapy After High Dose Methotrexate Based Chemotherapy In Patients With Newly Diagnosed Primary Central Nervous System … Annals Of Oncology. 2018; 29, Ix22

  • R Sahoo, M Patekar, N Adhikari, A Biswas, V Raina, L Kumar, A Sharma, A. Gogia, .Primary Central Nervous System Lymphoma In India: A 17-Year Experience From Aiims. ...Clinical Lymphoma, Myeloma And Leukemia. 2018; 18, S286

  • S Mallick, Mr Lone, P Ramteke, S Purokait, A. Gogia, A Batra, S Bakhshi. ClinicoPathological Profile AndCmyc Immunoreactivity Of Alk Positive Large B Cell Lymphoma: Report Of Nine Cases. ...Hematological Oncology. 2017; 35, 395-396

  • V Ramalingam, S Hari, Sb Paul, S Thulkar, S Vyas, A. Gogia, Svs Deo. Assessment Of Response To Neo-Adjuvant Chemotherapy In Breast Carcinoma Using Shear Wave Elastography., ...European Congress Of Radiology-2017; Ecr 2017

  • Ck Das, A. Gogia, Nk Shukla, S Deo, S Mathur, D Sharma. 121p Prognostic Significance Of The Derived Neutrophil Lymphocyte Ratio In Metastatic Breast Cancer: A Tertiary Cancer Care Center Analysis From India. Annals Of Oncology. 2016; 27, Ix36

  • A. Gogia, V Raina. An Update Analysis Of Rituximab Based Chemotherapy In Chronic Lymphocytic Leukaemia Patients: An Indian Scenario. Haematologica. 2014; 99, 585-585

  • A. Gogia, V Raina, A Sharma, L Kumar, R Gupta, S Vishnubhatla. Smudge Cells On Routine Blood Smear Predict Clinical Outcome In Chronic Lymphocytic Leukemia: An Institutional Study., ...Leukemia& Lymphoma. 2013; 54, 5-6

  • A. Gogia, V Raina, S Deo, B Mohanti, N Shukla. An Overview of Male Breast Cancer: 17 Years experience From A Single Centre. Breast. 2013; 22, S47-S47

  • R Upadhyay, DN Sharma, AK Gandhi, K Haresh, S Deo, A. Gogia, .Role of radiation therapy and its impact on survival of male breast cancer patients: experience from a tertiary cancer center. …International Journal of Radiation Oncology, Biology, Physics. 2016; 96 (2), E29

  • N Harivenkatesh,L Kumar, S Bakshi, A Sharma, M Kabra, T Velpandian, A. Gogia, .Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in patients with chronic myeloid leukemia. - Cancer Research. 2016; 76 (14 Supplement), 2040-2040

  • A. Gogia,V Raina, A Sharma, L Kumar. Safety and efficacy of rituximab based chemotherapy in chronic lymphocytic leukaemia patients: A single centre experience. European Journal of Cancer. 2013; 49, S844-S845

  • H Imran, T Pranay, S. V. S. Deo, A. Gogia,A study of PIK3CA gene mutation and its association with hormone receptor positive and HER2 receptor negative in breast cancer patients". Conference Paper. October 2017. 1st Annual Indian Breast Cancer Conference

 

BOOK CHAPTERS (5)

  • Hormone-dependent Malignancies in Elderly: Endometrium, Breast and Prostate, Text book of Geriatric Medicine 2015

  • Role of Autologous Transplant in hematological Malignancies, Recent Advance in Hematology 2016

  • Basics of Cancer Biology and Therapy: Update in Onco-Anaesthesia 2019

  • Applied Aspects of Systemic Therapy in Breast Oncoplasty and Reconstruction Breast Oncoplasty and Reconstruction: Principles and Practice 2023

  • Arora S, Gogia A. Tumour Lysis Syndrome. In: Kumar, V., Gupta, N., Mishra, S.(eds) Onco-critical Care. Springer, Singapore. (2022)

  

 

Photo gallery ( International  Fellowship)

Article in India Today Magazine ( Nov 21, 2016)

 

Photo gallery ( FREE MEDICAL CAMP AT LEH AND DHARAMSHALA)

 

Photo gallery (FREE MEDICAL CAMP AT magdod ,lEH,AWARD)

 

Photo gallery (mskcc visit)

 

Photo gallery (WITH HIS HOLLINESS DALAI LAMA)

 

 

 

 

Zo2 Framework Settings

Select one of sample color schemes

Google Font

Menu Font
Body Font
Heading Font

Body

Background Color
Text Color
Link Color
Background Image

Header Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Menu Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Main Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Inset Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Bottom Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image
Background Color
Modules Title
Text Color
Link Color
Background Image
 
Top of Page
BCMath lib not installed. RSA encryption unavailable